Skip to main content

Gavir Bek

CFO

Anthem Biosciences Limited

Equibles does not estimate personal net worth.

About Gavir Bek

Gavir Bek is recorded as CFO at Anthem Biosciences Limited. Gavir Bek has spoken on 3 earnings calls across 1 company, most recently for Anthem Biosciences Limited on July 22, 2026. Anthem Biosciences Limited is classified in the Biotechnology industry within the Healthcare sector.

Gavir Bek on recent calls

“See, with respect to our capacity utilization, last year, when we ended the year, roughly about unit 1 was about 74% utilized. We continue to have the same utilization in our unit 1, and even this quarter, roughly about 78% utilized right now on the custom synthesis side.”
CFO, Earnings Call for the Quarter Ended June 30, 2026 ·
“Benthi, I just want to add something over here. Historically, if you look at it, last 10 years, our revenue growth has been around 20% level. Even when we started last year, we said that we were delivering about 20%, but then we course corrected and then we delivered about 15% revenue growth.”
CFO, Anthem Biosciences Limited Q4 & FY26 Earnings Conference Call ·
“So Vivek, with respect to our nine-month performance, although revenue has grown at about 11-12%, we will have a strong finish to the year, quarter four. It has traditionally been the highest quarter for us because that's the nature of the CDMO business, and we should be looking at a good quarter of four as well.”
CFO, “Anthem Biosciences Limited Q3 & 9M FY26 Earning Conference Call” ·

Affiliation history

  • Anthem Biosciences Limited

    CFO

    Transcript header (unverified)

    Current

Company network

Anthem Biosciences Limited

Current role

Biotechnology · Healthcare

CFO

3 appearances Latest appearance 2026-07-22

Recent activity

  • Earnings call

    Earnings Call for the Quarter Ended June 30, 2026

    Anthem Biosciences Limited

  • Earnings call

    Anthem Biosciences Limited Q4 & FY26 Earnings Conference Call

    Anthem Biosciences Limited

  • Earnings call

    “Anthem Biosciences Limited Q3 & 9M FY26 Earning Conference Call”

    Anthem Biosciences Limited